Royal Bank of Canada
CDIO icon

Royal Bank of Canada’s Cardio Diagnostics CDIO Stock Holding History

Royal Bank of Canada’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,500
Closed -$27K – 7158
2025
Q2 		$27K Buy
+7,500
New +$56.1K ﹤0.01% 6160

Other funds holding CDIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Royal Bank of Canada's CDIO Position: Q3 2025 in Review

Royal Bank of Canada sold out of Cardio Diagnostics (CDIO) in Q3 2025, closing a stake of 7,500 shares — an estimated $27K sold.

Royal Bank of Canada first reported a position in CDIO in Q2 2025 and held it in 1 quarter. The position peaked at $27K in Q2 2025. 14 funds tracked by Wall St. Rank hold CDIO as of Q3 2025.

  • Royal Bank of Canada reported no remaining Cardio Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 7,500 Cardio Diagnostics shares in Q3 2025, an estimated $27K.
  • Royal Bank of Canada first reported a position in Cardio Diagnostics in Q2 2025 and held it in 1 quarter.
  • Royal Bank of Canada's Cardio Diagnostics position peaked at $27K in Q2 2025.
  • 14 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q3 2025.

Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.